other material
confidence high
sentiment negative
materiality 0.55
GOLDENWELL BIOTECH, INC. (GWLL): auditor change — Goldenwell Biotech to restate three quarterly reports over $9,840 legal fee timing errors
GOLDENWELL BIOTECH, INC.
- Auditor notified company on May 19, 2025 that legal invoice for $9,840 should have been recorded in service periods (May 2024–Sep 2025), not when received.
- Restatements affect March 31, June 30, and September 30, 2025 Form 10-Qs with additional revenue recognition and prepaid fee classification errors.
- Previously issued financial statements for those quarters should no longer be relied upon regarding the $9,840 legal expense.
- Amendments expected by approximately June 30, 2026; each quarter to recognize $2,280, $2,200, and $2,080 respectively.